{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:01:52Z","timestamp":1794290512147,"version":"4.9.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41581-025-00950-5","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:43:05Z","timestamp":1743770585000},"page":"417-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["From fat to filter: the effect of adipose tissue-derived signals on kidney function"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-8085","authenticated-orcid":false,"given":"Nermin","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0552-2260","authenticated-orcid":false,"given":"Carolina","family":"Dalmasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7411-1469","authenticated-orcid":false,"given":"Meghan B.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Cincinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia S.","family":"Loria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"950_CR1","unstructured":"Centers for Disease Control and Prevention. Chronic kidney disease in the United States, 2023. https:\/\/www.cdc.gov\/kidneydisease\/publications-resources\/CKD-national-facts.html (2024)."},{"key":"950_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13450","volume":"23","author":"JI Mart\u00ednez-Montoro","year":"2022","unstructured":"Mart\u00ednez-Montoro, J. I., Morales, E., Cornejo-Pareja, I., Tinahones, F. J. & Fern\u00e1ndez-Garc\u00eda, J. C. Obesity-related glomerulopathy: current approaches and future perspectives. Obes. Rev. 23, e13450 (2022).","journal-title":"Obes. Rev."},{"key":"950_CR3","doi-asserted-by":"publisher","first-page":"100568","DOI":"10.1016\/j.xkme.2022.100568","volume":"5","author":"AN Friedman","year":"2023","unstructured":"Friedman, A. N., Ogden, C. L. & Hales, C. M. Prevalence of obesity and CKD among adults in the United States, 2017\u20132020. Kidney Med. 5, 100568 (2023).","journal-title":"Kidney Med."},{"key":"950_CR4","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","volume":"324","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z. et al. Obesity and chronic kidney disease. Am. J. Physiol. Endocrinol. Metab. 324, E24\u2013E41 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"950_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","volume":"1801","author":"S Virtue","year":"2010","unstructured":"Virtue, S. & Vidal-Puig, A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome \u2014 an allostatic perspective. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1801, 338\u2013349 (2010).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"950_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D\u2019Agati","year":"2016","unstructured":"D\u2019Agati, V. D. et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol. 12, 453\u2013471 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","volume":"15","author":"JE Hall","year":"2019","unstructured":"Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z. & Hall, M. E. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat. Rev. Nephrol. 15, 367\u2013385 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","volume":"2","author":"AP de Vries","year":"2014","unstructured":"de Vries, A. P. et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2, 417\u2013426 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"950_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.ajkd.2006.07.025","volume":"48","author":"HM Chen","year":"2006","unstructured":"Chen, H. M. et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am. J. Kidney Dis. 48, 772\u2013779 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"950_CR10","doi-asserted-by":"publisher","first-page":"bvaa029","DOI":"10.1210\/jendso\/bvaa029","volume":"4","author":"I Kravets","year":"2020","unstructured":"Kravets, I. & Mallipattu, S. K. The role of podocytes and podocyte-associated biomarkers in diagnosis and treatment of diabetic kidney disease. J. Endocr. Soc. 4, bvaa029 (2020).","journal-title":"J. Endocr. Soc."},{"key":"950_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000507997","volume":"6","author":"H Trimarchi","year":"2020","unstructured":"Trimarchi, H. Mechanisms of podocyte detachment, podocyturia, and risk of progression of glomerulopathies. Kidney Dis. 6, 324\u2013329 (2020).","journal-title":"Kidney Dis."},{"key":"950_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s10020-023-00732-4","volume":"29","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Research progress on multiple cell death pathways of podocytes in diabetic kidney disease. Mol. Med. 29, 135 (2023).","journal-title":"Mol. Med."},{"key":"950_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41574-024-00951-7","volume":"20","author":"K Yau","year":"2024","unstructured":"Yau, K., Kuah, R., Cherney, D. Z. I. & Lam, T. K. T. Obesity and the kidney: mechanistic links and therapeutic advances. Nat. Rev. Endocrinol. 20, 321\u2013335 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"950_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ekir.2017.01.007","volume":"2","author":"N Tsuboi","year":"2017","unstructured":"Tsuboi, N., Okabayashi, Y., Shimizu, A. & Yokoo, T. The renal pathology of obesity. Kidney Int. Rep. 2, 251\u2013260 (2017).","journal-title":"Kidney Int. Rep."},{"key":"950_CR15","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/ASN.2010080793","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21, 1819\u20131834 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"950_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/nu14071457","volume":"14","author":"S Czaja-Stolc","year":"2022","unstructured":"Czaja-Stolc, S., Potrykus, M., Stankiewicz, M., Kaska, \u0141. & Ma\u0142gorzewicz, S. Pro-inflammatory profile of adipokines in obesity contributes to pathogenesis, nutritional disorders, and cardiovascular risk in chronic kidney disease. Nutrients 14, 1457 (2022).","journal-title":"Nutrients"},{"key":"950_CR17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen, M., Hill, M. A., Cohen, P. & Sowers, J. R. Obesity, adipose tissue and vascular dysfunction. Circ. Res. 128, 951\u2013968 (2021).","journal-title":"Circ. Res."},{"key":"950_CR18","first-page":"200165","volume":"16","author":"CA Couch","year":"2023","unstructured":"Couch, C. A., Fowler, L. A., Goss, A. M. & Gower, B. A. Associations of renal sinus fat with blood pressure and ectopic fat in a diverse cohort of adults. Int. J. Cardiol. Cardiovasc. Risk Prev. 16, 200165 (2023).","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"950_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.23876\/j.krcp.18.0155","volume":"38","author":"L D\u2019Marco","year":"2019","unstructured":"D\u2019Marco, L. et al. Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease. Kidney Res. Clin. Pract. 38, 365\u2013372 (2019).","journal-title":"Kidney Res. Clin. Pract."},{"key":"950_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10334-019-00773-z","volume":"33","author":"KA Spit","year":"2020","unstructured":"Spit, K. A. et al. Renal sinus fat and renal hemodynamics: a cross-sectional analysis. MAGMA 33, 73\u201380 (2020).","journal-title":"MAGMA"},{"key":"950_CR21","doi-asserted-by":"publisher","first-page":"122866","DOI":"10.1016\/j.lfs.2024.122866","volume":"352","author":"X Qiu","year":"2024","unstructured":"Qiu, X. et al. The role of perirenal adipose tissue deposition in chronic kidney disease progression: mechanisms and therapeutic implications. Life Sci. 352, 122866 (2024).","journal-title":"Life Sci."},{"key":"950_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4239\/wjd.v11.i4.115","volume":"11","author":"N Huang","year":"2020","unstructured":"Huang, N. et al. Novel insight into perirenal adipose tissue: a neglected adipose depot linking cardiovascular and chronic kidney disease. World J. Diabetes 11, 115\u2013125 (2020).","journal-title":"World J. Diabetes"},{"key":"950_CR23","doi-asserted-by":"publisher","first-page":"707126","DOI":"10.3389\/fendo.2021.707126","volume":"12","author":"SH Hammoud","year":"2021","unstructured":"Hammoud, S. H., AlZaim, I., Al-Dhaheri, Y., Eid, A. H. & El-Yazbi, A. F. Perirenal adipose tissue inflammation: novel insights linking metabolic dysfunction to renal diseases. Front. Endocrinol. 12, 707126 (2021).","journal-title":"Front. Endocrinol."},{"key":"950_CR24","doi-asserted-by":"crossref","unstructured":"Kotsis, V., Martinez, F., Trakatelli, C. & Redon, J. Impact of obesity in kidney diseases. Nutrients 13, 4482 (2021).","DOI":"10.3390\/nu13124482"},{"key":"950_CR25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z. & Hall, M. E. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ. Res. 116, 991\u20131006 (2015).","journal-title":"Circ. Res."},{"key":"950_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/1753-0407.13232","volume":"14","author":"C Mende","year":"2022","unstructured":"Mende, C. & Einhorn, D. Fatty kidney disease: the importance of ectopic fat deposition and the potential value of imaging. J. Diabetes 14, 73\u201378 (2022).","journal-title":"J. Diabetes"},{"key":"950_CR27","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1111\/1440-1681.13556","volume":"48","author":"BBA Castro","year":"2021","unstructured":"Castro, B. B. A., Foresto-Neto, O., Saraiva-Camara, N. O. & Sanders-Pinheiro, H. Renal lipotoxicity: insights from experimental models. Clin. Exp. Pharmacol. Physiol. 48, 1579\u20131588 (2021).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"950_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova, A., Merscher, S. & Fornoni, A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat. Rev. Nephrol. 19, 629\u2013645 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/metabo5040720","volume":"5","author":"P Mount","year":"2015","unstructured":"Mount, P., Davies, M., Choy, S. W., Cook, N. & Power, D. Obesity-related chronic kidney disease \u2014 the role of lipid metabolism. Metabolites 5, 720\u2013732 (2015).","journal-title":"Metabolites"},{"key":"950_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","volume":"81","author":"Y Hou","year":"2024","unstructured":"Hou, Y. et al. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney. Cell Mol. Life Sci. 81, 23 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"950_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan, Q., Tang, B. & Zhang, C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal. Transduct. Target. Ther. 7, 182 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"950_CR32","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","volume":"10","author":"F Zatterale","year":"2019","unstructured":"Zatterale, F. et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front. Physiol. 10, 1607 (2019).","journal-title":"Front. Physiol."},{"key":"950_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-physiol-032122-030352","volume":"85","author":"D Samovski","year":"2023","unstructured":"Samovski, D., Jacome-Sosa, M. & Abumrad, N. A. Fatty acid transport and signaling: mechanisms and physiological implications. Annu. Rev. Physiol. 85, 317\u2013337 (2023).","journal-title":"Annu. Rev. Physiol."},{"key":"950_CR34","doi-asserted-by":"publisher","first-page":"20240918","DOI":"10.1515\/med-2024-0918","volume":"19","author":"W Hua","year":"2024","unstructured":"Hua, W. et al. CD36-mediated podocyte lipotoxicity promotes foot process effacement. Open Med. 19, 20240918 (2024).","journal-title":"Open Med."},{"key":"950_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Short-chain fatty acids in diseases. Cell Commun. Signal. 21, 212 (2023).","journal-title":"Cell Commun. Signal."},{"key":"950_CR36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat. Rev. Nephrol. 13, 769\u2013781 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR37","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori, Y. et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metab. 33, 1042\u20131061.e7 (2021).","journal-title":"Cell Metab."},{"key":"950_CR38","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.3390\/ijms20143406","volume":"20","author":"X Zhao","year":"2019","unstructured":"Zhao, X. et al. Kidney injury molecule-1 is upregulated in renal lipotoxicity and mediates palmitate-induced tubular cell injury and inflammatory response. Int. J. Mol. Sci. 20, 3406 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"950_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/nu11040722","volume":"11","author":"Z Gai","year":"2019","unstructured":"Gai, Z. et al. Lipid accumulation and chronic kidney disease. Nutrients 11, 629\u2013645 (2019).","journal-title":"Nutrients"},{"key":"950_CR40","first-page":"3172647","volume":"2019","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. CD36-mediated lipid accumulation and activation of nlrp3 inflammasome lead to podocyte injury in obesity-related glomerulopathy. Mediators Inflamm. 2019, 3172647 (2019).","journal-title":"Mediators Inflamm."},{"key":"950_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172963","volume":"134","author":"D Mukhi","year":"2023","unstructured":"Mukhi, D. et al. ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. J. Clin. Invest. 134, e172963 (2023).","journal-title":"J. Clin. Invest."},{"key":"950_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","volume":"10","author":"LA Cassis","year":"2008","unstructured":"Cassis, L. A., Police, S. B., Yiannikouris, F. & Thatcher, S. E. Local adipose tissue renin-angiotensin system. Curr. Hypertens. Rep. 10, 93\u201398 (2008).","journal-title":"Curr. Hypertens. Rep."},{"key":"950_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1152\/physiol.00037.2016","volume":"32","author":"MT Schutten","year":"2017","unstructured":"Schutten, M. T., Houben, A. J., de Leeuw, P. W. & Stehouwer, C. D. The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology 32, 197\u2013209 (2017).","journal-title":"Physiology"},{"key":"950_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11906-012-0245-z","volume":"14","author":"T Thethi","year":"2012","unstructured":"Thethi, T., Kamiyama, M. & Kobori, H. The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr. Hypertens. Rep. 14, 160\u2013169 (2012).","journal-title":"Curr. Hypertens. Rep."},{"key":"950_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","volume":"31","author":"HM Siragy","year":"2010","unstructured":"Siragy, H. M. & Carey, R. M. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am. J. Nephrol. 31, 541\u2013550 (2010).","journal-title":"Am. J. Nephrol."},{"key":"950_CR46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","volume":"63","author":"VC Biancardi","year":"2014","unstructured":"Biancardi, V. C., Son, S. J., Ahmadi, S., Filosa, J. A. & Stern, J. E. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 63, 572\u2013579 (2014).","journal-title":"Hypertension"},{"key":"950_CR47","first-page":"027012","volume":"2006","author":"S Kim","year":"2006","unstructured":"Kim, S. et al. The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J. Biomed. Biotechnol. 2006, 027012 (2006).","journal-title":"J. Biomed. Biotechnol."},{"key":"950_CR48","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1124\/pharmrev.120.000236","volume":"74","author":"H Lin","year":"2022","unstructured":"Lin, H. et al. Kidney angiotensin in cardiovascular disease: formation and drug targeting. Pharmacol. Rev. 74, 462\u2013505 (2022).","journal-title":"Pharmacol. Rev."},{"key":"950_CR49","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","volume":"59","author":"AM Briones","year":"2012","unstructured":"Briones, A. M. et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 59, 1069\u20131078 (2012).","journal-title":"Hypertension"},{"key":"950_CR50","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ki.2014.348","volume":"87","author":"K Hosoya","year":"2015","unstructured":"Hosoya, K. et al. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. Kidney Int. 87, 749\u2013760 (2015).","journal-title":"Kidney Int."},{"key":"950_CR51","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1681\/ASN.2007101079","volume":"19","author":"G Remuzzi","year":"2008","unstructured":"Remuzzi, G., Cattaneo, D. & Perico, N. The aggravating mechanisms of aldosterone on kidney fibrosis. J. Am. Soc. Nephrol. 19, 1459\u20131462 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"950_CR52","doi-asserted-by":"publisher","first-page":"H989","DOI":"10.1152\/ajpheart.00073.2018","volume":"315","author":"AP Davel","year":"2018","unstructured":"Davel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F. & Belin de Chantemele, E. J. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects. Am. J. Physiol. Heart Circ. Physiol 315, H989\u2013H999 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"950_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41581-019-0160-5","volume":"15","author":"A Ichihara","year":"2019","unstructured":"Ichihara, A. & Yatabe, M. S. The (pro)renin receptor in health and disease. Nat. Rev. Nephrol. 15, 693\u2013712 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR54","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.molmet.2016.08.009","volume":"5","author":"Z Shamansurova","year":"2016","unstructured":"Shamansurova, Z. et al. Adipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight. Mol. Metab. 5, 959\u2013969 (2016).","journal-title":"Mol. Metab."},{"key":"950_CR55","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1016\/j.ijcard.2013.04.176","volume":"168","author":"A Fukushima","year":"2013","unstructured":"Fukushima, A. et al. Increased plasma soluble (pro)renin receptor levels are correlated with renal dysfunction in patients with heart failure. Int. J. Cardiol. 168, 4313\u20134314 (2013).","journal-title":"Int. J. Cardiol."},{"key":"950_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-021-00374-3","volume":"12","author":"B Visniauskas","year":"2021","unstructured":"Visniauskas, B. et al. Sex differences in soluble prorenin receptor in patients with type 2 diabetes. Biol. Sex. Differ. 12, 33 (2021).","journal-title":"Biol. Sex. Differ."},{"key":"950_CR57","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/HYPERTENSIONAHA.119.12906","volume":"74","author":"E Gatineau","year":"2019","unstructured":"Gatineau, E., Gong, M. C. & Yiannikouris, F. Soluble prorenin receptor increases blood pressure in high fat-fed male mice. Hypertension 74, 1014\u20131020 (2019).","journal-title":"Hypertension"},{"key":"950_CR58","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1042\/CS20201047","volume":"135","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor. Clin. Sci. 135, 793\u2013810 (2021).","journal-title":"Clin. Sci."},{"key":"950_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/HJH.0000000000000825","volume":"34","author":"S Quadri","year":"2016","unstructured":"Quadri, S. & Siragy, H. M.(Pro)renin receptor contributes to regulation of renal epithelial sodium channel. J. Hypertens. 34, 486\u2013494 (2016).","journal-title":"J. Hypertens."},{"key":"950_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrneph.2017.157","volume":"14","author":"Q Zhu","year":"2018","unstructured":"Zhu, Q. & Scherer, P. E. Immunologic and endocrine functions of adipose tissue: implications for kidney disease. Nat. Rev. Nephrol. 14, 105\u2013120 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0394632016643550","volume":"29","author":"A Mascali","year":"2016","unstructured":"Mascali, A. et al. Obesity and kidney disease: beyond the hyperfiltration. Int. J. Immunopathol. Pharmacol. 29, 354\u2013363 (2016).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"950_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1172\/JCI119532","volume":"100","author":"WG Haynes","year":"1997","unstructured":"Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L. & Sivitz, W. I. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100, 270\u2013278 (1997).","journal-title":"J. Clin. Invest."},{"key":"950_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/157340210791170994","volume":"6","author":"K Rahmouni","year":"2010","unstructured":"Rahmouni, K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr. Hypertens. Rev. 6, 104\u2013209 (2010).","journal-title":"Curr. Hypertens. Rev."},{"key":"950_CR64","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","volume":"117","author":"JE Hall","year":"2021","unstructured":"Hall, J. E. et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc. Res. 117, 1859\u20131876 (2021).","journal-title":"Cardiovasc. Res."},{"key":"950_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cellimm.2007.09.004","volume":"252","author":"R Lago","year":"2008","unstructured":"Lago, R., Gomez, R., Lago, F., Gomez-Reino, J. & Gualillo, O. Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell Immunol. 252, 139\u2013145 (2008).","journal-title":"Cell Immunol."},{"key":"950_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117828","volume":"10","author":"C Pedone","year":"2015","unstructured":"Pedone, C. et al. Longitudinal association between serum leptin concentration and glomerular filtration rate in humans. PLoS ONE 10, e0117828 (2015).","journal-title":"PLoS ONE"},{"key":"950_CR67","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.3390\/ijms22094685","volume":"22","author":"J Korczynska","year":"2021","unstructured":"Korczynska, J., Czumaj, A., Chmielewski, M., Swierczynski, J. & Sledzinski, T. The causes and potential injurious effects of elevated serum leptin levels in chronic kidney disease patients. Int. J. Mol. Sci. 22, 4685 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"950_CR68","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.biocel.2016.08.031","volume":"79","author":"JF Briffa","year":"2016","unstructured":"Briffa, J. F., Grinfeld, E., Poronnik, P., McAinch, A. J. & Hryciw, D. H. Uptake of leptin and albumin via separate pathways in proximal tubule cells. Int. J. Biochem. Cell Biol. 79, 194\u2013198 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"950_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2014.11.024","volume":"401","author":"JF Briffa","year":"2015","unstructured":"Briffa, J. F. et al. Acute leptin exposure reduces megalin expression and upregulates TGF\u03b21 in cultured renal proximal tubule cells. Mol. Cell Endocrinol. 401, 25\u201334 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"950_CR70","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/HYPERTENSIONAHA.111.00405","volume":"61","author":"CN Young","year":"2013","unstructured":"Young, C. N., Morgan, D. A., Butler, S. D., Mark, A. L. & Davisson, R. L. The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension 61, 737\u2013744 (2013).","journal-title":"Hypertension"},{"key":"950_CR71","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1152\/jn.00254.2023","volume":"130","author":"M Patel","year":"2023","unstructured":"Patel, M. et al. Central mechanisms in sympathetic nervous dysregulation in obesity. J. Neurophysiol. 130, 1414\u20131424 (2023).","journal-title":"J. Neurophysiol."},{"key":"950_CR72","doi-asserted-by":"publisher","first-page":"F1167","DOI":"10.1152\/ajprenal.00234.2014","volume":"308","author":"J Zhao","year":"2015","unstructured":"Zhao, J., Miyamoto, S., You, Y. H. & Sharma, K. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys. Am. J. Physiol. Renal Physiol 308, F1167\u2013F1177 (2015).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"950_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.semnephrol.2012.12.005","volume":"33","author":"MP Nasrallah","year":"2013","unstructured":"Nasrallah, M. P. & Ziyadeh, F. N. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin. Nephrol. 33, 54\u201365 (2013).","journal-title":"Semin. Nephrol."},{"key":"950_CR74","doi-asserted-by":"publisher","first-page":"R379","DOI":"10.1152\/ajpregu.00079.2019","volume":"318","author":"C Dalmasso","year":"2020","unstructured":"Dalmasso, C., Leachman, J. R., Osborn, J. L. & Loria, A. S. Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex. Am. J. Physiol. Regul. Integr. Comp. Physiol 318, R379\u2013R389 (2020).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"950_CR75","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/apha.12182","volume":"210","author":"XQ Xiong","year":"2014","unstructured":"Xiong, X. Q., Chen, W. W. & Zhu, G. Q. Adipose afferent reflex: sympathetic activation and obesity hypertension. Acta Physiol. 210, 468\u2013478 (2014).","journal-title":"Acta Physiol."},{"key":"950_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10799893.2018.1431278","volume":"38","author":"S Mao","year":"2018","unstructured":"Mao, S. et al. Leptin and chronic kidney diseases. J. Recept. Signal. Transduct. Res. 38, 89\u201394 (2018).","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"950_CR77","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/antiox9080752","volume":"9","author":"A Podkowi\u0144ska","year":"2020","unstructured":"Podkowi\u0144ska, A. & Formanowicz, D. Chronic kidney disease as oxidative stress- and inflammatory-mediated cardiovascular disease. Antioxidants 9, 752 (2020).","journal-title":"Antioxidants"},{"key":"950_CR78","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1046\/j.1523-1755.2001.0590041315.x","volume":"59","author":"DC Han","year":"2001","unstructured":"Han, D. C. et al. Leptin stimulates type I collagen production in db\/db mesangial cells: glucose uptake and TGF-\u03b2 type II receptor expression. Kidney Int. 59, 1315\u20131323 (2001).","journal-title":"Kidney Int."},{"key":"950_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122265","volume":"10","author":"K Thieme","year":"2015","unstructured":"Thieme, K. & Oliveira-Souza, M. Renal hemodynamic and morphological changes after 7 and 28 days of leptin treatment: the participation of angiotensin II via the AT1 receptor. PLoS ONE 10, e0122265 (2015).","journal-title":"PLoS ONE"},{"key":"950_CR80","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.3390\/ijms24098128","volume":"24","author":"H-H Chen","year":"2023","unstructured":"Chen, H.-H. et al. Chronic kidney disease: interaction of adiponectin gene polymorphisms and diabetes. Int. J. Mol. Sci. 24, 8128 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"950_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/jrms.JRMS_1115_17","volume":"23","author":"S Vahdat","year":"2018","unstructured":"Vahdat, S. The complex effects of adipokines in the patients with kidney disease. J. Res. Med. Sci. 23, 60 (2018).","journal-title":"J. Res. Med. Sci."},{"key":"950_CR82","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.3390\/ijms21249375","volume":"21","author":"J Przybyci\u0144ski","year":"2020","unstructured":"Przybyci\u0144ski, J., Dziedziejko, V., Pucha\u0142owicz, K., Doma\u0144ski, L. & Pawlik, A. Adiponectin in chronic kidney disease. Int. J. Mol. Sci. 21, 9375 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"950_CR83","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/nu13041180","volume":"13","author":"K Khoramipour","year":"2021","unstructured":"Khoramipour, K. et al. Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition. Nutrients 13, 1180 (2021).","journal-title":"Nutrients"},{"key":"950_CR84","first-page":"1619","volume":"118","author":"RS Ahima","year":"2008","unstructured":"Ahima, R. S. Linking adiponectin to proteinuria. J. Clin. Invest. 118, 1619\u20131622 (2008).","journal-title":"J. Clin. Invest."},{"key":"950_CR85","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/ATVBAHA.107.147645","volume":"27","author":"K Ohashi","year":"2007","unstructured":"Ohashi, K. et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler. Thromb. Vasc. Biol. 27, 1910\u20131917 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"950_CR86","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1210\/en.2016-1765","volume":"158","author":"D Zha","year":"2017","unstructured":"Zha, D., Wu, X. & Gao, P. Adiponectin and its receptors in diabetic kidney disease: molecular mechanisms and clinical potential. Endocrinology 158, 2022\u20132034 (2017).","journal-title":"Endocrinology"},{"key":"950_CR87","first-page":"1645","volume":"118","author":"K Sharma","year":"2008","unstructured":"Sharma, K. et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 118, 1645\u20131656 (2008).","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 4","key":"950_CR88","first-page":"iv15","volume":"28","author":"S Miyamoto","year":"2013","unstructured":"Miyamoto, S. & Sharma, K. Adipokines protecting CKD. Nephrol. Dial. Transpl. 28 (Suppl. 4) iv15\u2013iv22 (2013).","journal-title":"Nephrol. Dial. Transpl."},{"key":"950_CR89","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/ijms20071782","volume":"20","author":"Y Kim","year":"2019","unstructured":"Kim, Y. & Park, C. W. Mechanisms of adiponectin action: implication of adiponectin receptor agonism in diabetic kidney disease. Int. J. Mol. Sci. 20, 1782 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"950_CR90","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3390\/nu16152436","volume":"16","author":"S Baldelli","year":"2024","unstructured":"Baldelli, S. et al. The role of adipose tissue and nutrition in the regulation of adiponectin. Nutrients 16, 2436 (2024).","journal-title":"Nutrients"},{"key":"950_CR91","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.acthis.2015.12.011","volume":"118","author":"Y Slyvka","year":"2016","unstructured":"Slyvka, Y. et al. Antioxidant diet and sex interact to regulate NOS isoform expression and glomerular mesangium proliferation in Zucker diabetic rat kidney. Acta Histochem. 118, 183\u2013193 (2016).","journal-title":"Acta Histochem."},{"key":"950_CR92","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/ndt\/gfu249","volume":"29","author":"MP Martinez Cantarin","year":"2014","unstructured":"Martinez Cantarin, M. P., Keith, S. W., Waldman, S. A. & Falkner, B. Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease. Nephrol. Dial. Transpl. 29, 2268\u20132277 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"950_CR93","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/ph15121485","volume":"15","author":"CH Park","year":"2022","unstructured":"Park, C. H. & Yoo, T. H. TGF-\u03b2 inhibitors for therapeutic management of kidney fibrosis. Pharmaceuticals 15, 1485 (2022).","journal-title":"Pharmaceuticals"},{"key":"950_CR94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","volume":"85","author":"SR Choi","year":"2018","unstructured":"Choi, S. R. et al. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy. Metabolism 85, 348\u2013360 (2018).","journal-title":"Metabolism"},{"key":"950_CR95","doi-asserted-by":"publisher","first-page":"6","DOI":"10.23876\/j.krcp.18.0143","volume":"38","author":"HS Jang","year":"2019","unstructured":"Jang, H. S., Kim, J. & Padanilam, B. J. Renal sympathetic nerve activation via \u03b12-adrenergic receptors in chronic kidney disease progression. Kidney Res. Clin. Pract. 38, 6\u201314 (2019).","journal-title":"Kidney Res. Clin. Pract."},{"key":"950_CR96","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","volume":"101","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment. Biomed. Pharmacother. 101, 670\u2013681 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"950_CR97","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1681\/ASN.2011010026","volume":"22","author":"AE Decl\u00e8ves","year":"2011","unstructured":"Decl\u00e8ves, A. E., Mathew, A. V., Cunard, R. & Sharma, K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 22, 1846\u20131855 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"950_CR98","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.2147\/DDDT.S171286","volume":"12","author":"N Du","year":"2018","unstructured":"Du, N. et al. Combination of ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-\u03b21\/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy. Drug. Des. Devel. Ther. 12, 3517\u20133524 (2018).","journal-title":"Drug. Des. Devel. Ther."},{"key":"950_CR99","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.2337\/db09-1631","volume":"59","author":"J Li","year":"2010","unstructured":"Li, J. et al. Blockade of endothelial-mesenchymal transition by a smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 59, 2612\u20132624 (2010).","journal-title":"Diabetes"},{"key":"950_CR100","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/j.ajkd.2022.03.006","volume":"80","author":"T Isakova","year":"2022","unstructured":"Isakova, T., Yanucil, C. & Faul, C. A klotho-derived peptide as a possible novel drug to prevent kidney fibrosis. Am. J. Kidney Dis. 80, 285\u2013288 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"950_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28096-z","volume":"13","author":"Q Yuan","year":"2022","unstructured":"Yuan, Q. et al. A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-\u03b2 signaling. Nat. Commun. 13, 438 (2022).","journal-title":"Nat. Commun."},{"key":"950_CR102","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7150\/thno.89105","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation. Theranostics 14, 420\u2013435 (2024).","journal-title":"Theranostics"},{"key":"950_CR103","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1681\/ASN.V76914","volume":"7","author":"R Pai","year":"1996","unstructured":"Pai, R., Ha, H., Kirschenbaum, M. A. & Kamanna, V. S. Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J. Am. Soc. Nephrol. 7, 914\u2013923 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"950_CR104","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","volume":"3","author":"JK Sethi","year":"2021","unstructured":"Sethi, J. K. & Hotamisligil, G. S. Metabolic messengers: tumour necrosis factor. Nat. Metab. 3, 1302\u20131312 (2021).","journal-title":"Nat. Metab."},{"key":"950_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78376-1","volume":"10","author":"B Denhez","year":"2020","unstructured":"Denhez, B. et al. Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKK\u03b2 and mTORC1. Sci. Rep. 10, 21628 (2020).","journal-title":"Sci. Rep."},{"key":"950_CR106","doi-asserted-by":"publisher","first-page":"F821","DOI":"10.1152\/ajprenal.00196.2010","volume":"299","author":"J Sieber","year":"2010","unstructured":"Sieber, J. et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am. J. Physiol. Renal Physiol 299, F821\u2013829 (2010).","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"950_CR107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000340033","volume":"36","author":"FJ Therrien","year":"2012","unstructured":"Therrien, F. J., Agharazii, M., Lebel, M. & Larivi\u00e8re, R. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am. J. Nephrol. 36, 151\u2013161 (2012).","journal-title":"Am. J. Nephrol."},{"key":"950_CR108","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/1568010054022132","volume":"4","author":"JR Timoshanko","year":"2005","unstructured":"Timoshanko, J. R. & Tipping, P. G. Resident kidney cells and their involvement in glomerulonephritis. Curr. Drug. Targets Inflamm. Allergy 4, 353\u2013362 (2005).","journal-title":"Curr. Drug. Targets Inflamm. Allergy"},{"key":"950_CR109","doi-asserted-by":"publisher","first-page":"627837","DOI":"10.3389\/fphys.2021.627837","volume":"12","author":"H Tirichen","year":"2021","unstructured":"Tirichen, H. et al. Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Front. Physiol. 12, 627837 (2021).","journal-title":"Front. Physiol."},{"key":"950_CR110","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su, H., Lei, C. T. & Zhang, C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front. Immunol. 8, 405 (2017).","journal-title":"Front. Immunol."},{"key":"950_CR111","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ki.2009.503","volume":"77","author":"DV Barreto","year":"2010","unstructured":"Barreto, D. V. et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 77, 550\u2013556 (2010).","journal-title":"Kidney Int."},{"key":"950_CR112","first-page":"4196","volume":"82","author":"V Mohamed-Ali","year":"1997","unstructured":"Mohamed-Ali, V. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-\u03b1, in vivo. J. Clin. Endocrinol. Metab. 82, 4196\u20134200 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"950_CR113","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1210\/jc.2004-0603","volume":"89","author":"ME Trujillo","year":"2004","unstructured":"Trujillo, M. E. et al. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J. Clin. Endocrinol. Metab. 89, 5577\u20135582 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"950_CR114","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000059327","volume":"8","author":"I Coletta","year":"2000","unstructured":"Coletta, I. et al. Selective induction of MCP-1 in human mesangial cells by the IL-6\/sIL-6R complex. Exp. Nephrol. 8, 37\u201343 (2000).","journal-title":"Exp. Nephrol."},{"key":"950_CR115","doi-asserted-by":"publisher","first-page":"R590","DOI":"10.1152\/ajpregu.00207.2009","volume":"299","author":"K Li","year":"2010","unstructured":"Li, K. et al. Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells. Am. J. Physiol. Regul. Integr. Comp. Physiol 299, R590\u2013595 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"950_CR116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ki.2009.98","volume":"76","author":"TC Lu","year":"2009","unstructured":"Lu, T. C. et al. Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. Kidney Int. 76, 63\u201371 (2009).","journal-title":"Kidney Int."},{"key":"950_CR117","doi-asserted-by":"publisher","first-page":"654912","DOI":"10.3389\/fmed.2021.654912","volume":"8","author":"FC Paquissi","year":"2021","unstructured":"Paquissi, F. C. & Abensur, H. The Th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis. Front. Med. 8, 654912 (2021).","journal-title":"Front. Med."},{"key":"950_CR118","doi-asserted-by":"publisher","first-page":"897105","DOI":"10.3389\/fphys.2022.897105","volume":"13","author":"H Yun","year":"2022","unstructured":"Yun, H. et al. The chemerin-CMKLR1 axis is functionally important for central regulation of energy homeostasis. Front. Physiol. 13, 897105 (2022).","journal-title":"Front. Physiol."},{"key":"950_CR119","doi-asserted-by":"publisher","first-page":"1120774","DOI":"10.3389\/fendo.2023.1120774","volume":"14","author":"AH Behnoush","year":"2023","unstructured":"Behnoush, A. H. et al. Chemerin levels in chronic kidney disease: a systematic review and meta-analysis. Front. Endocrinol. 14, 1120774 (2023).","journal-title":"Front. Endocrinol."},{"key":"950_CR120","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.vph.2015.08.010","volume":"77","author":"A Leiherer","year":"2016","unstructured":"Leiherer, A. et al. High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events \u2014 insights from phenotype and genotype characterization. Vasc. Pharmacol. 77, 60\u201368 (2016).","journal-title":"Vasc. Pharmacol."},{"key":"950_CR121","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tice.2018.09.002","volume":"54","author":"K Habas","year":"2018","unstructured":"Habas, K. & Shang, L. Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cells. Tissue Cell 54, 139\u2013143 (2018).","journal-title":"Tissue Cell"},{"key":"950_CR122","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/ajh\/hpv132","volume":"29","author":"CY Hsu","year":"2016","unstructured":"Hsu, C. Y. et al. Increased circulating visfatin is associated with progression of kidney disease in non-diabetic hypertensive patients. Am. J. Hypertens. 29, 528\u2013536 (2016).","journal-title":"Am. J. Hypertens."},{"key":"950_CR123","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/j.ajkd.2006.11.021","volume":"49","author":"J Axelsson","year":"2007","unstructured":"Axelsson, J. et al. Circulating levels of visfatin\/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am. J. Kidney Dis. 49, 237\u2013244 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"950_CR124","doi-asserted-by":"publisher","first-page":"F1485","DOI":"10.1152\/ajprenal.90231.2008","volume":"295","author":"HK Song","year":"2008","unstructured":"Song, H. K. et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am. J. Physiol. Renal Physiol. 295, F1485\u20131494 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"950_CR125","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/07435800.2010.539992","volume":"36","author":"Q Huang","year":"2011","unstructured":"Huang, Q. et al. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Endocr. Res. 36, 93\u2013100 (2011).","journal-title":"Endocr. Res."},{"key":"950_CR126","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.bbalip.2010.09.001","volume":"1801","author":"KM Boini","year":"2010","unstructured":"Boini, K. M. et al. Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells. Biochim. Biophys. Acta 1801, 1294\u20131304 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"950_CR127","doi-asserted-by":"publisher","first-page":"166146","DOI":"10.1016\/j.bbadis.2021.166146","volume":"1867","author":"D Huang","year":"2021","unstructured":"Huang, D. et al. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166146 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"950_CR128","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/jim-2021-002008","volume":"70","author":"X Fan","year":"2022","unstructured":"Fan, X. et al. Interleukin-10 attenuates renal injury after myocardial infarction in diabetes. J. Investig. Med. 70, 1233\u20131242 (2022).","journal-title":"J. Investig. Med."},{"key":"950_CR129","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7326\/M22-3078","volume":"176","author":"M Fang","year":"2023","unstructured":"Fang, M., Jeon, Y., Echouffo-Tcheugui, J. B. & Selvin, E. Prevalence and management of obesity in U.S. adults with type 1 diabetes. Ann. Intern. Med. 176, 427\u2013429 (2023).","journal-title":"Ann. Intern. Med."},{"key":"950_CR130","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.pop.2020.08.004","volume":"47","author":"R Bonner","year":"2020","unstructured":"Bonner, R., Albajrami, O., Hudspeth, J. & Upadhyay, A. Diabetic kidney disease. Prim. Care 47, 645\u2013659 (2020).","journal-title":"Prim. Care"},{"key":"950_CR131","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","volume":"129","author":"DZ Cherney","year":"2014","unstructured":"Cherney, D. Z. et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 129, 587\u2013597 (2014).","journal-title":"Circulation"},{"key":"950_CR132","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1530\/EC-21-0097","volume":"10","author":"E Nordheim","year":"2021","unstructured":"Nordheim, E. & Geir Jenssen, T. Chronic kidney disease in patients with diabetes mellitus. Endocr. Connect. 10, R151\u2013R159 (2021).","journal-title":"Endocr. Connect."},{"key":"950_CR133","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.maturitas.2011.11.009","volume":"71","author":"R Pyram","year":"2012","unstructured":"Pyram, R., Kansara, A., Banerji, M. A. & Loney-Hutchinson, L. Chronic kidney disease and diabetes. Maturitas 71, 94\u2013103 (2012).","journal-title":"Maturitas"},{"key":"950_CR134","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.freeradbiomed.2010.03.021","volume":"48","author":"E Katsoulieris","year":"2010","unstructured":"Katsoulieris, E. et al. Lipotoxicity in renal proximal tubular cells: relationship between endoplasmic reticulum stress and oxidative stress pathways. Free. Radic. Biol. Med. 48, 1654\u20131662 (2010).","journal-title":"Free. Radic. Biol. Med."},{"key":"950_CR135","doi-asserted-by":"publisher","first-page":"655871","DOI":"10.3389\/fmed.2021.655871","volume":"8","author":"C Garc\u00eda-Carro","year":"2021","unstructured":"Garc\u00eda-Carro, C. et al. A nephrologist perspective on obesity: from kidney injury to clinical management. Front. Med. 8, 655871 (2021).","journal-title":"Front. Med."},{"key":"950_CR136","doi-asserted-by":"publisher","first-page":"4709715","DOI":"10.1155\/2019\/4709715","volume":"2019","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Hyperinsulinemia can cause kidney disease in the IGT stage of OLETF rats via the INS\/IRS-1\/PI3-K\/Akt signaling pathway. J. Diabetes Res. 2019, 4709715 (2019).","journal-title":"J. Diabetes Res."},{"key":"950_CR137","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000479801","volume":"8","author":"A Whaley-Connell","year":"2017","unstructured":"Whaley-Connell, A. & Sowers, J. R. Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity. Cardiorenal Med. 8, 41\u201349 (2017).","journal-title":"Cardiorenal Med."},{"key":"950_CR138","doi-asserted-by":"publisher","first-page":"1133352","DOI":"10.3389\/fneph.2023.1133352","volume":"3","author":"R Daza-Arnedo","year":"2023","unstructured":"Daza-Arnedo, R. et al. Insulin and the kidneys: a contemporary view on the molecular basis. Front. Nephrol. 3, 1133352 (2023).","journal-title":"Front. Nephrol."},{"key":"950_CR139","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/biomedicines10102374","volume":"10","author":"G Brosolo","year":"2022","unstructured":"Brosolo, G. et al. Insulin resistance and high blood pressure: mechanistic insight on the role of the kidney. Biomedicines 10, 2374 (2022).","journal-title":"Biomedicines"},{"key":"950_CR140","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","volume":"30","author":"L Zeni","year":"2017","unstructured":"Zeni, L., Norden, A. G. W., Cancarini, G. & Unwin, R. J. A more tubulocentric view of diabetic kidney disease. J. Nephrol. 30, 701\u2013717 (2017).","journal-title":"J. Nephrol."},{"key":"950_CR141","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2337\/db16-0796","volume":"66","author":"RE Gilbert","year":"2017","unstructured":"Gilbert, R. E. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes 66, 791\u2013800 (2017).","journal-title":"Diabetes"},{"key":"950_CR142","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1172\/JCI119163","volume":"99","author":"ME Pagtalunan","year":"1997","unstructured":"Pagtalunan, M. E. et al. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99, 342\u2013348 (1997).","journal-title":"J. Clin. Invest."},{"key":"950_CR143","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon, V. & Thomson, S. C. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat. Rev. Nephrol. 16, 317\u2013336 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"950_CR144","doi-asserted-by":"publisher","DOI":"10.1097\/IN9.0000000000000023","volume":"5","author":"E Serrano","year":"2023","unstructured":"Serrano, E., Shenoy, P. & Martinez Cantarin, M. P. Adipose tissue metabolic changes in chronic kidney disease. Immunometabolism 5, e00023 (2023).","journal-title":"Immunometabolism"},{"key":"950_CR145","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/toxins12080502","volume":"12","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. et al. Indoxyl sulfate contributes to adipose tissue inflammation through the activation of NADPH oxidase. Toxins 12, 502 (2020).","journal-title":"Toxins"},{"key":"950_CR146","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder, R. et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934\u20131943 (2003).","journal-title":"Kidney Int."},{"key":"950_CR147","doi-asserted-by":"crossref","unstructured":"Glassock, R. J. & Massry, S. G. in Nutritional Management of Renal Disease 4th edn. (eds Kopple, J. D., Massry, S. G., Kalantar-Zadeh, K., & Fouque, D.) 77\u201389 (Academic Press, 2022).","DOI":"10.1016\/B978-0-12-818540-7.00015-X"},{"key":"950_CR148","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/nu12061814","volume":"12","author":"H Nishi","year":"2020","unstructured":"Nishi, H., Takemura, K., Higashihara, T. & Inagi, R. Uremic sarcopenia: clinical evidence and basic experimental approach. Nutrients 12, 1814 (2020).","journal-title":"Nutrients"},{"key":"950_CR149","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ki.2008.195","volume":"74","author":"HL Zhao","year":"2008","unstructured":"Zhao, H. L. et al. Fat redistribution and adipocyte transformation in uninephrectomized rats. Kidney Int. 74, 467\u2013477 (2008).","journal-title":"Kidney Int."},{"key":"950_CR150","doi-asserted-by":"publisher","unstructured":"Stocker, S. D., Kinsman, B. J. & Sved, A. F. Recent advances in neurogenic hypertension: dietary salt, obesity, and inflammation. Hypertension https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.08936 (2017).","DOI":"10.1161\/HYPERTENSIONAHA.117.08936"},{"key":"950_CR151","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11906-016-0658-1","volume":"18","author":"JM do Carmo","year":"2016","unstructured":"do Carmo, J. M. et al. Obesity-induced hypertension: brain signaling pathways. Curr. Hypertens. Rep. 18, 58 (2016).","journal-title":"Curr. Hypertens. Rep."},{"key":"950_CR152","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.111.00633","volume":"61","author":"GF DiBona","year":"2013","unstructured":"DiBona, G. F. Sympathetic nervous system and hypertension. Hypertension 61, 556\u2013560 (2013).","journal-title":"Hypertension"},{"key":"950_CR153","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/HYPERTENSIONAHA.116.07993","volume":"68","author":"N Asirvatham-Jeyaraj","year":"2016","unstructured":"Asirvatham-Jeyaraj, N. et al. Renal denervation normalizes arterial pressure with no effect on glucose metabolism or renal inflammation in obese hypertensive mice. Hypertension 68, 929\u2013936 (2016).","journal-title":"Hypertension"},{"key":"950_CR154","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","volume":"33","author":"C Ott","year":"2015","unstructured":"Ott, C. et al. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension. J. Hypertens. 33, 1261\u20131266 (2015).","journal-title":"J. Hypertens."},{"key":"950_CR155","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.1002\/ccd.26068","volume":"87","author":"D Id","year":"2016","unstructured":"Id, D. et al. Predictors of blood pressure response: obesity is associated with a less pronounced treatment response after renal denervation. Catheter. Cardiovasc. Interv. 87, E30\u2013E38 (2016).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"950_CR156","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1152\/ajpregu.00351.2014","volume":"308","author":"UC Kopp","year":"2015","unstructured":"Kopp, U. C. Role of renal sensory nerves in physiological and pathophysiological conditions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308, R79\u2013R95 (2015).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"950_CR157","doi-asserted-by":"crossref","unstructured":"Tyshynsky, R., Vulchanova, L. & Osborn, J. in Renal Denervation: Treatment and Device-Based Neuromodulation. (eds Heuser, R. R., Schlaich, M. P., Hering, D., & Bertog, S. C.) 3\u20139 (Springer International Publishing, 2023).","DOI":"10.1007\/978-3-031-38934-4_1"},{"key":"950_CR158","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1161\/HYPERTENSIONAHA.118.11676","volume":"73","author":"EA Lambert","year":"2019","unstructured":"Lambert, E. A. et al. Obesity-associated organ damage and sympathetic nervous activity. Hypertension 73, 1150\u20131159 (2019).","journal-title":"Hypertension"},{"key":"950_CR159","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.3390\/ijms24076207","volume":"24","author":"SQ Yu","year":"2023","unstructured":"Yu, S. Q., Ma, S. & Wang, D. H. Activation of TRPV1-expressing renal sensory nerves of rats with N-oleoyldopamine attenuates high-fat-diet-induced impairment of renal function. Int. J. Mol. Sci. 24, 6207 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"950_CR160","doi-asserted-by":"publisher","first-page":"R883","DOI":"10.1152\/ajpregu.00416.2017","volume":"314","author":"CT Banek","year":"2018","unstructured":"Banek, C. T. et al. Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 314, R883\u2013R891 (2018).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"950_CR161","doi-asserted-by":"publisher","first-page":"R262","DOI":"10.1152\/ajpregu.00408.2015","volume":"310","author":"JD Foss","year":"2016","unstructured":"Foss, J. D., Fink, G. D. & Osborn, J. W. Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, R262\u2013R267 (2016).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"950_CR162","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1042\/CS20190412","volume":"133","author":"W Cao","year":"2019","unstructured":"Cao, W. et al. Adipocytes initiate an adipose-cerebral-peripheral sympathetic reflex to induce insulin resistance during high-fat feeding. Clin. Sci. 133, 1883\u20131899 (2019).","journal-title":"Clin. Sci."},{"key":"950_CR163","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/apha.12502","volume":"214","author":"L Ding","year":"2015","unstructured":"Ding, L. et al. Adipose afferent reflex response to insulin is mediated by melanocortin 4 type receptors in the paraventricular nucleus in insulin resistance rats. Acta Physiol. 214, 450\u2013466 (2015).","journal-title":"Acta Physiol."},{"key":"950_CR164","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1161\/HYPERTENSIONAHA.112.198002","volume":"60","author":"XQ Xiong","year":"2012","unstructured":"Xiong, X. Q. et al. Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension 60, 1280\u20131286 (2012).","journal-title":"Hypertension"},{"key":"950_CR165","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-1838(98)00109-X","volume":"73","author":"A Niijima","year":"1998","unstructured":"Niijima, A. Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J. Autonomic Nerv. Syst. 73, 19\u201325 (1998).","journal-title":"J. Autonomic Nerv. Syst."},{"key":"950_CR166","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0304-3940(99)00054-3","volume":"262","author":"A Niijima","year":"1999","unstructured":"Niijima, A. Reflex effects from leptin sensors in the white adipose tissue of the epididymis to the efferent activity of the sympathetic and vagus nerve in the rat. Neurosci. Lett. 262, 125\u2013128 (1999).","journal-title":"Neurosci. Lett."},{"key":"950_CR167","doi-asserted-by":"publisher","first-page":"E1338","DOI":"10.1152\/ajpendo.00021.2013","volume":"304","author":"KT Murphy","year":"2013","unstructured":"Murphy, K. T. et al. Leptin-sensitive sensory nerves innervate white fat. Am. J. Physiol. Endocrinol. Metab. 304, E1338\u2013E1347 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"950_CR168","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3940(00)01490-7","volume":"293","author":"M Tanida","year":"2000","unstructured":"Tanida, M., Iwashita, S., Ootsuka, Y., Terui, N. & Suzuki, M. Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats. Neurosci. Lett. 293, 107\u2013110 (2000).","journal-title":"Neurosci. Lett."},{"key":"950_CR169","doi-asserted-by":"publisher","first-page":"R501","DOI":"10.1152\/ajpregu.90786.2008","volume":"296","author":"CK Song","year":"2009","unstructured":"Song, C. K., Schwartz, G. J. & Bartness, T. J. Anterograde transneuronal viral tract tracing reveals central sensory circuits from white adipose tissue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R501\u2013R511 (2009).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"950_CR170","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1152\/japplphysiol.01164.2011","volume":"112","author":"Z Shi","year":"2012","unstructured":"Shi, Z. et al. Sympathetic activation by chemical stimulation of white adipose tissues in rats. J. Appl. Physiol. 112, 1008\u20131014 (2012).","journal-title":"J. Appl. Physiol."},{"key":"950_CR171","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.physbeh.2007.04.002","volume":"91","author":"TJ Bartness","year":"2007","unstructured":"Bartness, T. J. & Song, C. K. Brain-adipose tissue neural crosstalk. Physiol. Behav. 91, 343\u2013351 (2007).","journal-title":"Physiol. Behav."},{"key":"950_CR172","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.yfrne.2014.04.001","volume":"35","author":"TJ Bartness","year":"2014","unstructured":"Bartness, T. J., Liu, Y., Shrestha, Y. B. & Ryu, V. Neural innervation of white adipose tissue and the control of lipolysis. Front. Neuroendocrinol. 35, 473\u2013493 (2014).","journal-title":"Front. Neuroendocrinol."},{"key":"950_CR173","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jne.12252","volume":"27","author":"JE Stern","year":"2015","unstructured":"Stern, J. E. Neuroendocrine-autonomic integration in the paraventricular nucleus: novel roles for dendritically released neuropeptides. J. Neuroendocrinol. 27, 487\u2013497 (2015).","journal-title":"J. Neuroendocrinol."},{"key":"950_CR174","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40292-016-0137-4","volume":"23","author":"G Seravalle","year":"2016","unstructured":"Seravalle, G. & Grassi, G. Sympathetic nervous system, hypertension, obesity and metabolic syndrome. High. Blood Press. Cardiovasc. Prev. 23, 175\u2013179 (2016).","journal-title":"High. Blood Press. Cardiovasc. Prev."},{"key":"950_CR175","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yfrne.2017.10.005","volume":"48","author":"AD de Kloet","year":"2018","unstructured":"de Kloet, A. D. & Herman, J. P. Fat-brain connections: adipocyte glucocorticoid control of stress and metabolism. Front. Neuroendocrinol. 48, 50\u201357 (2018).","journal-title":"Front. Neuroendocrinol."},{"key":"950_CR176","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1161\/HYPERTENSIONAHA.121.17298","volume":"78","author":"C Dalmasso","year":"2021","unstructured":"Dalmasso, C. et al. Epididymal fat-derived sympathoexcitatory signals exacerbate neurogenic hypertension in obese male mice exposed to early life stress. Hypertension 78, 1434\u20131449 (2021).","journal-title":"Hypertension"},{"key":"950_CR177","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-019-0165-y","volume":"15","author":"A Guilherme","year":"2019","unstructured":"Guilherme, A., Henriques, F., Bedard, A. H. & Czech, M. P. Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus. Nat. Rev. Endocrinol. 15, 207\u2013225 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"950_CR178","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0022-3565(25)23196-2","volume":"255","author":"J Szolcsanyi","year":"1990","unstructured":"Szolcsanyi, J., Szallasi, A., Szallasi, Z., Joo, F. & Blumberg, P. M. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons. J. Pharmacol. Exp. Ther. 255, 923\u2013928 (1990).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"950_CR179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083771","volume":"8","author":"L Ding","year":"2013","unstructured":"Ding, L. et al. Superoxide anions in paraventricular nucleus modulate adipose afferent reflex and sympathetic activity in rats. PLoS ONE 8, e83771 (2013).","journal-title":"PLoS ONE"},{"key":"950_CR180","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ebiom.2018.10.054","volume":"37","author":"W Cao","year":"2018","unstructured":"Cao, W. et al. A renal-cerebral-peripheral sympathetic reflex mediates insulin resistance in chronic kidney disease. EBioMedicine 37, 281\u2013293 (2018).","journal-title":"EBioMedicine"},{"key":"950_CR181","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/apha.12125","volume":"209","author":"BP Cui","year":"2013","unstructured":"Cui, B. P. et al. Ionotropic glutamate receptors in paraventricular nucleus mediate adipose afferent reflex and regulate sympathetic outflow in rats. Acta Physiol. 209, 45\u201354 (2013).","journal-title":"Acta Physiol."},{"key":"950_CR182","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41586-022-05137-7","volume":"609","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. The role of somatosensory innervation of adipose tissues. Nature 609, 569\u2013574 (2022).","journal-title":"Nature"},{"key":"950_CR183","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cmet.2017.08.016","volume":"26","author":"H Jiang","year":"2017","unstructured":"Jiang, H., Ding, X., Cao, Y., Wang, H. & Zeng, W. Dense intra-adipose sympathetic arborizations are essential for cold-induced beiging of mouse white adipose tissue. Cell Metab. 26, 686\u2013692.e683 (2017).","journal-title":"Cell Metab."},{"key":"950_CR184","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.neuropharm.2012.04.034","volume":"63","author":"F Qiu","year":"2012","unstructured":"Qiu, F. et al. Potentiation of acid-sensing ion channel activity by the activation of 5-HT(2) receptors in rat dorsal root ganglion neurons. Neuropharmacology 63, 494\u2013500 (2012).","journal-title":"Neuropharmacology"},{"key":"950_CR185","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fnins.2018.00930","volume":"12","author":"P Van Dyken","year":"2018","unstructured":"Van Dyken, P. & Lacoste, B. Impact of metabolic syndrome on neuroinflammation and the blood-brain barrier. Front. Neurosci. 12, 930 (2018).","journal-title":"Front. Neurosci."},{"key":"950_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03104-9","volume":"21","author":"Z Feng","year":"2024","unstructured":"Feng, Z., Fang, C., Ma, Y. & Chang, J. Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms. J. Neuroinflammation 21, 110 (2024).","journal-title":"J. Neuroinflammation"},{"key":"950_CR187","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s42255-024-01079-8","volume":"6","author":"O Le Thuc","year":"2024","unstructured":"Le Thuc, O. & Garcia-Caceres, C. Obesity-induced inflammation: connecting the periphery to the brain. Nat. Metab. 6, 1237\u20131252 (2024).","journal-title":"Nat. Metab."},{"key":"950_CR188","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.2337\/db12-1605","volume":"62","author":"JP Thaler","year":"2013","unstructured":"Thaler, J. P., Guyenet, S. J., Dorfman, M. D., Wisse, B. E. & Schwartz, M. W. Hypothalamic inflammation: marker or mechanism of obesity pathogenesis? Diabetes 62, 2629\u20132634 (2013).","journal-title":"Diabetes"},{"key":"950_CR189","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1403-x","volume":"16","author":"MA Malkiewicz","year":"2019","unstructured":"Malkiewicz, M. A. et al. Blood-brain barrier permeability and physical exercise. J. Neuroinflammation 16, 15 (2019).","journal-title":"J. Neuroinflammation"},{"key":"950_CR190","doi-asserted-by":"publisher","first-page":"798995","DOI":"10.3389\/fnint.2022.798995","volume":"16","author":"V Salas-Venegas","year":"2022","unstructured":"Salas-Venegas, V. et al. The obese brain: mechanisms of systemic and local inflammation, and interventions to reverse the cognitive deficit. Front. Integr. Neurosci. 16, 798995 (2022).","journal-title":"Front. Integr. Neurosci."},{"key":"950_CR191","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","volume":"91","author":"C Garofalo","year":"2017","unstructured":"Garofalo, C. et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 91, 1224\u20131235 (2017).","journal-title":"Kidney Int."},{"key":"950_CR192","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41440-021-00643-z","volume":"44","author":"T Ghatage","year":"2021","unstructured":"Ghatage, T., Goyal, S. G., Dhar, A. & Bhat, A. Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies. Hypertension Res. 44, 740\u2013755 (2021).","journal-title":"Hypertension Res."},{"key":"950_CR193","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1681\/ASN.0000000000000245","volume":"35","author":"PE Pergola","year":"2024","unstructured":"Pergola, P. E. et al. Effect of ziltivekimab on determinants of hemoglobin in patients with CKD stage 3\u20135: an analysis of a randomized trial (RESCUE). J. Am. Soc. Nephrol. 35, 74\u201384 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"950_CR194","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jamacardio.2022.4277","volume":"8","author":"NH Adamstein","year":"2023","unstructured":"Adamstein, N. H. et al. Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the RESCUE clinical trial. JAMA Cardiol. 8, 177\u2013181, (2023).","journal-title":"JAMA Cardiol."},{"key":"950_CR195","doi-asserted-by":"publisher","first-page":"sfae072","DOI":"10.1093\/ckj\/sfae072","volume":"17","author":"V Ivkovi\u0107","year":"2024","unstructured":"Ivkovi\u0107, V. & Bruchfeld, A. Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease. Clin. Kidney J. 17, sfae072 (2024).","journal-title":"Clin. Kidney J."},{"key":"950_CR196","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.123.21716","volume":"81","author":"EL Schiffrin","year":"2024","unstructured":"Schiffrin, E. L. & Pollock, D. M. Endothelin system in hypertension and chronic kidney disease. Hypertension 81, 691\u2013701 (2024).","journal-title":"Hypertension"},{"key":"950_CR197","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/oby.23331","volume":"30","author":"AJY Cheong","year":"2022","unstructured":"Cheong, A. J. Y. et al. SGLT inhibitors on weight and body mass: a meta-analysis of 116 randomized-controlled trials. Obesity 30, 117\u2013128 (2022).","journal-title":"Obesity"},{"key":"950_CR198","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137163","volume":"10","author":"B Zingerman","year":"2015","unstructured":"Zingerman, B. et al. Effect of acetazolamide on obesity-induced glomerular hyperfiltration: a randomized controlled trial. PLoS ONE 10, e0137163 (2015).","journal-title":"PLoS ONE"},{"key":"950_CR199","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4093\/dmj.2023.0067","volume":"47","author":"SH Suh","year":"2023","unstructured":"Suh, S. H. & Kim, S. W. Dyslipidemia in patients with chronic kidney disease: an updated overview. Diabetes Metab. J. 47, 612\u2013629 (2023).","journal-title":"Diabetes Metab. J."},{"key":"950_CR200","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N. Engl. J. Med. 391, 109\u2013121 (2024).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00950-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00950-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00950-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:02:00Z","timestamp":1747900920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00950-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":200,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-00950-5","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"5 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}